Inicio・Lista de Acciones・Geron Corp

Geron Corp

Cerrado

SectorSanidad

1.43 -0.69

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

1.42

Máximo

1.43

Métricas clave
By Trading Economics
Ingresos	25M -3.6M
Ventas	3.8M 52M
BPA	-0.005
Margen de beneficios	-7.026
Empleados	258
EBITDA	27M 3.8M

Recomendaciones
By TipRanks
Recomendaciones	Compra Fuerte
Estimación a 12 Meses	+181.69% upside

Dividendos
By Acuity
Próximas Ganancias	5 ago 2026

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	-82M 924M
Apertura anterior	2.12
Cierre anterior	1.43

Noticias sobre sentimiento de mercado

By Acuity

50%

152 / 340 Clasificación en Healthcare

Geron Corp Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

24 jul 2026, 19:46 UTC

Geron Corp shares are lower in Friday's session amid broader market volatility and uncertainty from fluctuating oil prices and new U.S. tariffs.

23 jul 2026, 10:11 UTC

Shares of Geron Corp are higher in pre-market hours, trading above their 20-day moving average. No specific company news was identified.

22 jul 2026, 18:51 UTC

Geron Corp shares are lower today amid broader market trends, as crude oil prices surge due to geopolitical tensions.

21 jul 2026, 23:41 UTC

Geron Corp shares are lower in after-market trading, declining to their lowest point since Tuesday's close. No specific news was identified to explain the drop.

20 jul 2026, 23:56 UTC

Geron Corp shares are lower in after-market hours, continuing a decline since Monday's close amid broader market uncertainties and a drop in the leading economic index.

Comparación entre iguales

Cambio de precio

Geron Corp previsión

Precio Objetivo

By TipRanks

181.69% repunte

Estimación a 12 Meses

Media 4 USD 181.69%

Máximo 5 USD

Mínimo 3 USD

De acuerdo con 4 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Geron Corp Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

4 ratings

Comprar

Mantener

Vender

De acuerdo con 4 analistas que ofrecen calificaciones bursátiles a para Geron Corp Dist en los últimos 3 meses.

Sentimiento

By Acuity

152 / 340 Clasificación en Sanidad

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Geron Corp

Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in myeloid hematologic malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes and intermediate-2 or high-risk myelofibrosis. The company was incorporated in 1990 and is headquartered in Foster City, California.